ArticleCureus2025
Unmasking the Long-Term Effects of COVID-19 With a Focus on Chronic Fatigue Syndrome: A Community-Based Study From India.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- A multinational cross-sectional study on the prevalence and predictors of long COVID across 33 countries.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background The COVID-19 pandemic has highlighted the enduring health burden of long COVID, scientifically termed the postacute sequelae of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection or PASC. Long COVID manifests as diverse symptoms affecting multiple organ systems, significantly impacting individuals globally, and especially underrepresented rural populations. Objective This study aimed to evaluate the prevalence of chronic fatigue syndrome (CFS) among laboratory-confirmed COVID-19 patients in rural India, focusing on identifying its predictors and the implications for healthcare systems in resource-limited settings. Methodology Retrospective data analysis was conducted on the follow-up visits of post-COVID-19 patients in the field practice area of AIIMS Mangalagiri, Nuthakki, Andhra Pradesh, India. The study involved 500 COVID-19 survivors diagnosed via reverse transcription polymerase chain reaction (RT-PCR) between 2023 and 2024. Data was collected via a semi-structured questionnaire to retrieve socio-demographic and clinical parameters, while CFS severity was assessed using a validated scoring system. Multivariable logistic regression and path analysis were used to examine the associations between the predictors of CFS. Results The prevalence of CFS was seen in 107 patients (21.4%; 95% CI: 18.01-25.22). Risk factors included older age (adjusted odds ratio or aOR: 15.90 for ≥60 years), female gender (aOR: 1.90), and comorbidities (aOR: 3.92). Common symptoms observed were fatigue in 180 (36%), joint pain in 185 (37%), and muscle pain in 182 (36.4%) patients. There was no significant association between vaccination and CFS. Conclusion The study underscores the substantial burden of post-COVID fatigue in rural populations, with female patients, older adults, and those with comorbidities being at greater risk. Tailored healthcare interventions and proactive post-COVID monitoring are critical to address this challenge. Future research should explore the underlying mechanisms and assess the role of vaccination in mitigating the post-COVID sequelae.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.